Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Propanc Biopharma ( (PPCB) ) has provided an announcement.
On June 20, 2025, Propanc Biopharma entered into a securities purchase agreement with an investor for a convertible promissory note valued at $67,860, sold for $58,000. The proceeds will be used for general working capital. The note, maturing on April 16, 2026, includes a 15% interest charge and allows for conversion into common stock at a 35% discount in case of default. The agreement outlines specific default events, which would make the note immediately payable.
More about Propanc Biopharma
Average Trading Volume: 2,626
Technical Sentiment Signal: Strong Sell
Current Market Cap: $48.19M
Learn more about PPCB stock on TipRanks’ Stock Analysis page.